Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.

作者: Regis T. Costello

DOI: 10.3109/02841869309093617

关键词:

摘要: Recombinant cytokines are now available for clinical use. Several colony-stimulating factors (CFS) have been identified which induce activation, proliferation and maturation of myeloid lineage cells. Recent therapeutic trials with granulocyte-macrophage (GM-CSF) in association chemotherapy, bone marrow transplantation leukemia treatment reviewed. GM-CSF as primary myelodysplasia other types failure is also interest. Colony-stimulating factor therapy AIDS may be useful order to reduce myelodepression caused by antiviral chemotherapy associated malignancies like Kaposi's sarcoma. However, the effect neutrophil count increase on infection far from clear, real benefit cancer has yet demonstrated.

参考文章(82)
B E Robinson, I A Tabbara, Hematopoietic growth factors. Anticancer Research. ,vol. 11, pp. 81- 90 ,(1991)
H. Anderson, H. Gurney, N. Thatcher, R. Swindell, J. H. Scarffe, J. Weiner, Recombinant Human GM-CSF in Small Cell Lung Cancer: A Phase I/II Study Recent results in cancer research. ,vol. 121, pp. 155- 161 ,(1991) , 10.1007/978-3-642-84138-5_17
S Saeland, C Caux, C Favre, V Duvert, MJ Pebusque, P Mannoni, JE deVries, Combined and sequential effects of human IL-3 and GM-CSF on the proliferation of CD34+ hematopoietic cells from cord blood Blood. ,vol. 73, pp. 1195- 1201 ,(1989) , 10.1182/BLOOD.V73.5.1195.1195
C Nissen, A Tichelli, A Gratwohl, B Speck, A Milne, EC Gordon-Smith, J Schaedelin, Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia Blood. ,vol. 72, pp. 2045- 2047 ,(1988) , 10.1182/BLOOD.V72.6.2045.2045